Placenta Previa
60
5
5
25
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.7%
1 terminated out of 60 trials
96.2%
+9.6% vs benchmark
10%
6 trials in Phase 3/4
4%
1 of 25 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 25 completed trials
Clinical Trials (60)
ERAS Protocol for Cesarean Delivery in Women With Placenta Previa
Placenta-Cervical Interface Angle for Predicting Placenta Accreta Spectrum Severity
Hematological and Coagulation Markers in Predicting Placenta Accreta Spectrum in Placenta Previa
Effect of a Cervical Pessary on the Rate of Bleeding in Placenta Praevia
Placenta Previa and Placenta Percreta Patients During the Third Trimester
Evaluation of Cervical Invasion and Length in Placenta Accreta Patients
Maternal Serum Adropin in Placenta Accreta Spectrum
Tranexamic Acid vs Vasopressin in Placenta Previa Trial
Intervention for Fear of Childbirth in High-Risk Pregnant Women
Outcomes of Placenta Accreta Spectrum Disorders Surgery in Relation to Placenta Accreta Scoring Index
Planned Delivery at 37 Versus 36 Weeks in Pregnancies With Placenta Previaand Accreta
Association of Assisted Reproductive Technologies Parameters With the Perinatal Outcome
Tranexamic Acid for the Prevention of Postpartum Hemorrhage in Pregnant Women With Placenta Previa
Syncytiotrophoblast-derived Extracellular Vesicles in Placenta Previa and Accreta Spectrum
Anxiety and Depressive Symptoms in Placenta Previa / Accreta
Causal Relationship Between Plasma VEGF Family Proteins and Placenta Previa: A Two-Sample Mendelian Randomization Study
Clinical Outcomes of Placenta Previa - an Individualized Scoring System
Long Term Comparison of Two Different Techniques of Uterine Cesarean Incision Closure
Sonographic Parameters and Risk of Antepartum Hemorrhage in Asymptomatic Women With Placenta Previa: A Cohort Study
Efficacy of Topical Tranexamic Acid in Reducing Blood Loss During CS in Patients With Placenta Previa